Patent · US Active

Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d

US12358976B2 · kind B2 · utility

0Cited by
15References
20Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 7, 2023
Grant dateJul 15, 2025
Priority date
Expiry dateAug 7, 2043

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/90
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compositions and methods for treating a hypophosphatemic disorder, such as X-linked hypophosphatemia (XLH). The method entails administering to a subject a pharmaceutical composition containing an anti-FGF23 ligand, wherein the dosing regimen of the pharmaceutical is designed to reach effective and efficient control of FGF23 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.